Lanean...
Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy
CA125, the most widely used ovarian cancer (OC) biomarker, was first identified approximately thirty-five years ago in an antibody screen against OC antigen. Two decades later, it was cloned and characterized to be a transmembrane mucin, MUC16. Since then several studies have investigated its expres...
Gorde:
| Argitaratua izan da: | Cancer Res |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4651718/ https://ncbi.nlm.nih.gov/pubmed/26527287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-1050 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|